Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 20, 2026

Total Value: $1.203B (100.0% shares, 0.0% debt)

Holdings (46)

Exited Positions (9)

Decreased Positions (9)

Unchanged Positions (24)

TNGX Tango Therapeutics Inc 3.7%
Value $45.08M Shares 2,154,780 Est. Cost $6.75 Unrealized +76.3%
DNTH Dianthus Therapeutics Inc 2.5%
Value $29.71M Shares 353,998 Est. Cost $25.56 Unrealized +86.2%
PEPG Pepgen Inc 0.3%
Value $4.115M Shares 2,325,000 Est. Cost $1.61 Unrealized +261.7%
NERV Minerva Neurosciences Inc 2.2%
Value $26.04M Shares 4,322,747 Est. Cost $3.71 Unrealized +33.7%
CAMP CAMP4 Therapeutics Inc 1.6%
Value $18.73M Shares 4,246,568 Est. Cost $2.04 Unrealized +129.2%
OLMA Olema Pharmaceuticals Inc 0.8%
Value $10.02M Shares 671,843 Est. Cost $31.43 Unrealized -19.0%
MLTX Moonlake Immunotherapeutics 1.5%
Value $18.64M Shares 1,000,000 Est. Cost $11.80 Unrealized +36.0%
ANRO Alto Neuroscience Inc 1.9%
Value $23.28M Shares 1,035,551 Est. Cost $12.59 Unrealized +33.1%
TRVI Trevi Therapeutics Inc 5.1%
Value $60.78M Shares 5,094,668 Est. Cost $4.23 Unrealized +158.5%
DSGN Design Therapeutics Inc 1.4%
Value $17.16M Shares 1,612,903 Est. Cost $7.83 Unrealized +27.5%
LBRX LB Pharmaceuticals Inc 1.6%
Value $19.73M Shares 800,000 Est. Cost $15.87 Unrealized +41.1%
SRZN Surrozen Inc 0.6%
Value $7.574M Shares 260,000 Est. Cost $11.62 Unrealized +91.2%
SERA Sera Prognostics Inc 0.3%
Value $3.35M Shares 1,650,440 Est. Cost $10.38 Unrealized -71.6%
UNCY Unicycive Therapeutics 1.0%
Value $11.78M Shares 1,789,916 Est. Cost $5.52 Unrealized +16.2%
KTTA Pasithea Therapeutics Corp 0.1%
Value $1.558M Shares 2,100,000 Est. Cost $0.88 Unrealized -2.3%
SABS SAB Biotherapeutics Inc 3.6%
Value $43.74M Shares 11,420,000 Est. Cost $2.26 Unrealized +77.0%
MNPR Monopar Therapeutics Inc 0.4%
Value $4.958M Shares 90,500 Est. Cost $44.70 Unrealized +40.5%
TIL Instil Bio Inc 0.2%
Value $2.412M Shares 292,743 Est. Cost $7.23 Unrealized +8.6%
TENX Tenax Therapeutics Inc 0.3%
Value $3.331M Shares 208,333 Est. Cost $3.62 Unrealized +272.6%
CMPX Compass Therapeutics Inc 4.2%
Value $50.5M Shares 9,545,466 Est. Cost $3.04 Unrealized +97.7%
EPRX Eupraxia Pharmaceuticals Inc 0.8%
Value $9.774M Shares 1,350,000 Est. Cost $5.44 Unrealized +53.9%
BOLT Bolt Therapeutics Inc 0.0%
Value $293K Shares 72,414 Est. Cost $6.62 Unrealized -13.4%
DTIL Precision Biosciences Inc 0.0%
Value $25,713 Shares 4,675 Est. Cost $12.24 Unrealized -67.3%
SVA Sinovac Biotech Ltd. 3.2%
Value $38.19M Shares 5,903,000 Est. Cost $6.47 Unrealized 0.0%